| Keywords: |
overall survival; note; cancer staging; methodology; cancer diagnosis; neoplasm staging; sensitivity and specificity; ovarian neoplasms; biological marker; ovary cancer; breast cancer; carcinoembryonic antigen; vascular cell adhesion molecule 1; tumor markers, biological; cancer screening; mass screening; editorial; pathology; tumor marker; blood; early diagnosis; ovary tumor; prediction and forecasting; predictive value of tests; immunoassay; ca 125 antigen; ca-125 antigen; postmenopause; early detection of cancer; predictive value; human epididymis protein 4; defb126 protein, human; epididymal secretory protein; transvaginal echography; epididymal secretory proteins; vascular cell adhesion molecule-1
|
